Pavan Bhargava, MD, looks forward to the 2025 Annual Meeting of the American Academy of Neurology, where attendees will learn about the updated diagnostic criteria for relapsing-remitting multiple sclerosis (RRMS), including a new application of MRI techniques that enhances both specificity and sensitivity. Presentations will cover the application of these updated criteria in diverse populations and explore the impact of social determinants of health on MS.
There will also be discussions on biomarkers for diagnosing and predicting outcomes in RRMS, as well as updates on new treatments. Experts will also provide insights into the role of diet in managing MS and improving patient outcomes.
AAN 2025: Previewing New Data in the Management of Relapsing-Remitting Multiple Sclerosis
DISCLOSURES March 24, 2025
Comments
Commenting is limited to medical professionals. To comment please Log-in.
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
